BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19153190)

  • 1. Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation.
    Beales IL; Ogunwobi OO
    J Mol Endocrinol; 2009 Apr; 42(4):305-18. PubMed ID: 19153190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine-extended gastrin stimulates proliferation via JAK2- and Akt-dependent NF-kappaB activation in Barrett's oesophageal adenocarcinoma cells.
    Ogunwobi OO; Beales IL
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):94-102. PubMed ID: 18771702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
    Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
    BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways.
    Ogunwobi OO; Beales IL
    Regul Pept; 2006 Mar; 134(1):1-8. PubMed ID: 16169610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
    Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin inhibits leptin-induced oncogenic signalling in oesophageal cancer cells by activation of PTP1B.
    Beales ILP; Garcia-Morales C; Ogunwobi OO; Mutungi G
    Mol Cell Endocrinol; 2014 Jan; 382(1):150-158. PubMed ID: 23994026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine-extended gastrin inhibits apoptosis in colon cancer cells via separate activation of Akt and JNK pathways.
    Beales IL; Ogunwobi O
    Mol Cell Endocrinol; 2006 Mar; 247(1-2):140-9. PubMed ID: 16442704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
    Ogunwobi OO; Beales IL
    Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.
    Dvorak K; Chavarria M; Payne CM; Ramsey L; Crowley-Weber C; Dvorakova B; Dvorak B; Bernstein H; Holubec H; Sampliner RE; Bernstein C; Prasad A; Green SB; Garewal H
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5305-13. PubMed ID: 17875759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of the JAK2/PI3K-mediated signaling activation is involved in Taiwan cobra cardiotoxin III-induced apoptosis of human breast MDA-MB-231 cancer cells.
    Lin KL; Su JC; Chien CM; Chuang PW; Chang LS; Lin SR
    Toxicon; 2010 Jun; 55(7):1263-73. PubMed ID: 20144642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation.
    Ogunwobi O; Mutungi G; Beales IL
    Endocrinology; 2006 Sep; 147(9):4505-16. PubMed ID: 16740977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest.
    Cheong E; Ivory K; Doleman J; Parker ML; Rhodes M; Johnson IT
    Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant inactivation of the epidermal growth factor receptor, phosphatidylinositol 3-kinase/Akt and Janus tyrosine kinase 2/signal transducer and activator of transcription 3 signalling pathways in cardiotoxin III-treated A549 cells.
    Su JC; Lin KL; Chien CM; Chuang PW; Chang LS; Lin SR
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):833-40. PubMed ID: 20456425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma.
    Jiménez P; Piazuelo E; Cebrian C; Ortego J; Strunk M; García-Gonzalez MA; Santander S; Alcedo J; Lanas A
    Aliment Pharmacol Ther; 2010 Feb; 31(3):440-51. PubMed ID: 19843025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor.
    Haigh CR; Attwood SE; Thompson DG; Jankowski JA; Kirton CM; Pritchard DM; Varro A; Dimaline R
    Gastroenterology; 2003 Mar; 124(3):615-25. PubMed ID: 12612900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naphtho[1,2-b]furan-4,5-dione disrupts Janus kinase-2 and induces apoptosis in breast cancer MDA-MB-231 cells.
    Lin KL; Su JC; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR
    Toxicol In Vitro; 2010 Jun; 24(4):1158-67. PubMed ID: 20197088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin acting on the cholecystokinin2 receptor induces cyclooxygenase-2 expression through JAK2/STAT3/PI3K/Akt pathway in human gastric cancer cells.
    Xu W; Chen GS; Shao Y; Li XL; Xu HC; Zhang H; Zhu GQ; Zhou YC; He XP; Sun WH
    Cancer Lett; 2013 May; 332(1):11-8. PubMed ID: 23376640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
    Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A
    Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.